Found: 6
Select item for more details and to access through your institution.
Dual‐Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug‐Resistant Cancer Therapy.
- Published in:
- Advanced Functional Materials, 2020, v. 30, n. 16, p. 1, doi. 10.1002/adfm.201910144
- By:
- Publication type:
- Article
Cancer Therapy: Dual-Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug-Resistant Cancer Therapy (Adv. Funct. Mater. 44/2017).
- Published in:
- Advanced Functional Materials, 2017, v. 27, n. 44, p. n/a, doi. 10.1002/adfm.201770260
- By:
- Publication type:
- Article
Dual-Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug-Resistant Cancer Therapy.
- Published in:
- Advanced Functional Materials, 2017, v. 27, n. 44, p. n/a, doi. 10.1002/adfm.201700403
- By:
- Publication type:
- Article
Gigantol ameliorates CCl4-induced liver injury via preventing activation of JNK/cPLA2/12-LOX inflammatory pathway.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-79400-0
- By:
- Publication type:
- Article
Design of a Novel Fab‐Like Antibody Fragment with Enhanced Stability and Affinity for Clinical use (Small Methods 2/2022).
- Published in:
- Small Methods, 2022, v. 6, n. 2, p. 1, doi. 10.1002/smtd.202270008
- By:
- Publication type:
- Article
Design of a Novel Fab‐Like Antibody Fragment with Enhanced Stability and Affinity for Clinical use.
- Published in:
- Small Methods, 2022, v. 6, n. 2, p. 1, doi. 10.1002/smtd.202100966
- By:
- Publication type:
- Article